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INTRODUCTION
It is now widely held that multiple subtypes of opioid receptors mediate the various physiological and behavioral effects of endogenous and exogenous opioids (for recent reviews see 1,210 A common theme in the description of multiple receptor subtypes is the attempt to ascribe particular functions to specific receptors (e-g. 3, 4) . Converging lines of evidence, from a variety of in vitro bioassays, receptor binding assays, and --in vivo pharmacological studies, points to an important role for the mu --receptor in mediation of analgesia (e.g. [5] [6] [7] . There are, however, reports that kappa and delta selective agents can also induce analgesia depending upon variables such as the route of administration and the type of pain inhibited (e.g. 7). In the present study, we have shown that morphine, the prototypic opiate analgesic and mu receptor agonist, selectively occupies mu opioid receptors in vivo following administration of pharmacologically relevant doses. Interestingly, following systemic administration of analgesic doses of morphine, a pronounced increase in the number of mu, but not delta or kappa, binding sites was observed. ME'IHODS Subjects were male Sprague-Dawley rats (200-25Og; Charles River Laboratories, Worcester,MA). Rats were injected subcutaneously with either morphine sulfate (5 mg/kg) or 0.9% saline 20 min prior to sacrifice by decapitation. Brains (minus cerebellum) were rapidly removed, placed in ice cold Tris buffer (50 mM, pB 7.4), and homogenized with a Brinkmsn Polytron. (8) . The receptor assay mixture was incubated on ice for 90 min in 96 well microtiter plates, filtered under vacuum on Schleicher and Schuell #32 glass fiber filters using a Brandel cell harvester, and the filters counted in a liquid scintillation counter.
Data for analysis were obtained in two ~ys.
For production of Scatchard plots, brains of three rats in each injection condition were pooled and the homogenate was assayed with radiolabelled ligands in concentrations ranging from 0.05 nM to 40 nM. Data from this experiment were analyzed using the computer program LIGAND (9) to obtain best fit estimates of the binding parameters KD and B,,.
For statistical comparison of the observed differences in binding between saline and morphine-injected groups, brains of individual rat $ from each group (n-6) were assayed with 0.5 and 5.0 nM of each of the [ ] ligands, and following one or two centrifugations. Group differences were tested using analysis of variance with repeated measures and Newman-Keuls tests for specific comparisons. A significance level of p < .Ol was used for all inferential statistics.
RESULTS
Morphine caused an apparent decrease in the binding capacity of brain membranes for the mu, but not the delta or kappa, ligands (Table 1) indicated by the observed decrease in the apparent KD after one centrifugation. That this difference represents receptor occupation by morphine is consistent with classically defined competitive binding models.
There was, however, an accompanying increase in B,,.
After the second centrifugation, membranes from morphine-injected brains showed a marked increase in the total number of mu, but not delta or binding sites (Table 1) . In this case, the apparent KDs for [ r-%GO $ binding are similar in control and morphine-injected homogenates suggesting successful elimination of bound morphine and the remaining effect being a marked increase in B,,.
Analysis of the data from animals assayed individually revealed the reduction of in vitro binding to be mu selective and statistically reliable. Moreover, the apparent increase mu binding in membranes centrifuged twice from morphine-injected rats was also significant and specific to the mu receptor. 
